Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
128 hedge funds and large institutions have $1.17B invested in Amicus Therapeutics in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 28 closing their positions.
107% more call options, than puts
Call options by funds: $23.3M | Put options by funds: $11.3M
34% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 38
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
8% less funds holding
Funds holding: 139 → 128 (-11)
13% less capital invested
Capital invested by funds: $1.34B → $1.17B (-$172M)
39% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$8.87M |
| 2 |
Jennison Associates
New York
|
+$7.2M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$7.06M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$3.7M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$9.47M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$7.05M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$5.96M |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$4.96M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.7M |
FOLD Hedge Fund Activity: Q1 2016 in Review
128 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q1 2016, worth a combined $1.17B — down 13% from $1.34B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of FOLD and 17 opened new positions — a net loss of 11 holders — while 38 trimmed existing stakes and 51 added.
The largest buyer was Sectoral Asset Management, adding an estimated $8.87M. The largest seller was State Street, cutting an estimated $9.47M.
- 128 institutional investors held Amicus Therapeutics (FOLD) as of Q1 2016, down from 139 in Q4 2015.
- Funds reported $1.17B of Amicus Therapeutics stock for Q1 2016, down 13% quarter-over-quarter.
- 17 funds opened new Amicus Therapeutics positions in Q1 2016 and 28 closed out, a net change of -11 holders.
- The largest Amicus Therapeutics buyer in Q1 2016 was Sectoral Asset Management, an estimated $8.87M added.
- The largest Amicus Therapeutics seller in Q1 2016 was State Street, an estimated $9.47M sold.
Based on aggregated 13F filings for Q1 2016.